Navigation Links
David Passov Named to PharmaVOICE 100

SAN FRANCISCO, Aug. 3, 2011 /PRNewswire/ -- ClinStar, LLC, an established CRO providing clinical research services in Russia and Eastern Europe to the pharmaceutical and biotechnology industry, is pleased to announce that President and CEO David Passov has been named one of the 100 most inspiring people in the life-sciences industry by PharmaVOICE magazine.


According to the editors at PharmaVOICE, "Recognizing the importance of emerging nations in improving recruitment for clinical trials, David Passov has been educating the industry about the huge potential open to it within Russia, Ukraine, Belarus and the Baltics. Mr. Passov works hard to dispel any rumors or myths about these markets, noting that the clear advantage of conducting clinical trials in markets such as Russia is that companies can enroll patients three to 20 times faster than in the United States and Western Europe."  In a recent interview with NPR, Mr. Passov "helped convey how ongoing drug research in Russia benefits the general population by providing quicker access to advanced healthcare that may otherwise not be available for years or ever at all."

"I am honored to receive this distinguished recognition from PharmaVOICE. It is a satisfying affirmation of the work we are doing in conjunction with the biopharmaceutical industry in the region, and ultimately, the positive impact we are having on bringing more advance healthcare to the people of Russia and Eastern Europe," says Mr. Passov.

Established seven years ago by PharmaVOICE magazine, the PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life-sciences industry. The distinguished honorees are nominated by thousands of PharmaVOICE readers and represent a broad cross section of industry sectors. Those chosen contribute to the growth and well-being of their individual companies, their communities and varied industry associations.

About ClinStar, LLC

ClinStar is one of the most prominent CROs in the emerging markets of Eastern Europe and the Baltics, with more than 10 years of expertise in Phase I-IV clinical studies in multiple therapeutic areas. Headquartered in San Francisco, California, ClinStar manages studies from its offices in Russia, Ukraine and Belarus, with total staff of nearly 300 people. Its portfolio contains over 130 clinical trials conducted for US and European pharmaceutical and biotechnology companies. More information is available at

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Proves McDavid Ankle Braces Significantly Prevent Injuries
2. DePuy ASR Hip Resurfacing System Failure Leads to Lawsuit, According to the Law Offices of John David Hart
3. Vicor Technologies CEO David H. Fater to Present Live, Online at
4. Robotic Prostatectomy Expert Dr. David Samadi on a High Impact Study Advocating Aggressive Early-Stage Prostate Cancer Treatment
5. Medco Chairman and CEO David Snow Addresses Shareholders, Highlighting Another Year of Growth, Innovation and Substantial Client Savings - With More to Come
6. Recalled DePuy ASR Hip Implant Lawsuits Filed By John David Hart
7. David M. Kendall, M.D., Named Distinguished Medical Fellow at Lilly
8. The Board of Directors of Kinex Pharmaceuticals Appoints Dr. David Hangauer as Chief Scientific Officer
9. Dr. David B. Samadi Discusses Why Robotic Surgery is Quickly Becoming the Go-To Standard for Prostate Cancer Treatment
10. Law Offices of John David Hart: DePuy Recalled Hip Device Lawsuit Filed by Houston Woman
11. St. Davids HealthCare Takes Robotic-Assisted Surgery to the Next Level With the Texas Institute for Robotic Surgery at St. Davids North Austin Medical Center
Post Your Comments:
(Date:11/27/2015)... Research and Markets ( ) has ... Market 2015-2019" report to their offering. ... report, the author the present scenario and growth prospects ... calculate the market size, the report considers revenue generated ... IUDs and copper IUDs. The report forecasts the global ...
(Date:11/26/2015)... Países Bajos, November 26, 2015 ... fotodinámica de Bremachlorin para el cáncer avanzado.   ... con la terapia fotodinámica de Bremachlorin para el cáncer ... enfoque combina la inmunoterapia con la terapia fotodinámica de ... Clinical Cancer Research . --> Clinical Cancer ...
(Date:11/26/2015)... Nederland, November 26, 2015 ... Een nieuwe aanpak combineert immunotherapie met Bremachlorin-photodynamische ... ) --> ...      (Photo: ) ... Universitair Medisch Centrum (LUMC) blijkt ...
Breaking Medicine Technology:
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... A team ... ways to treat it. Surviving Mesothelioma has just posted the findings on the ... University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated with ...
(Date:11/27/2015)... ... November 27, 2015 , ... ProSidebar: Fashion ... Cut Pro X. With ProSidebar: Fasion, video editors can easily add an informative ... a minimalist title opener. Utilize presets featuring self-animating drop zones, lines, bars, and ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you ... for not only fulfilling the needs of advisers and clients but going above ... and providing top-tier customer service. However, there's always room for improvement, which is ...
(Date:11/27/2015)... San Francisco, California (PRWEB) , ... November 27, 2015 , ... ... 1969 Janis Joplin Ann Arbor Michigan boxing style concert posters. This is one of ... 1969 at the Canterbury House at the University of Michigan in Ann Arbor. The ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... Representative. As a franchise owner, Somu now offers travelers, value and care based ... packages, private cruise sales, as well as, cabin upgrades and special amenities such ...
Breaking Medicine News(10 mins):